Evidence map›Paper›PMID 41383023›Full record

ReviewThe European journal of neuroscience2025

Nicotinic Receptors in the Medial Habenula to Interpeduncular Nucleus Pathway: Modulators of Reward, Aversion and Emotion.

Maria Ciscato, Mathilde Chouvaeff, Alexandre Mourot

Abstract readReview
In one paragraph

Review in The European journal of neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria CiscatoBrain Plasticity Unit, CNRS, ESPCI Paris, PSL Research University, Paris, France.
Mathilde ChouvaeffBrain Plasticity Unit, CNRS, ESPCI Paris, PSL Research University, Paris, France.
Alexandre MourotBrain Plasticity Unit, CNRS, ESPCI Paris, PSL Research University, Paris, France.ORCID 0000-0002-8839-7481

Funding

Agence Nationale de la Recherche ANR-10-IDEX-0001 PSL-NeuroAgence Nationale de la Recherche ANR-21-CE16-0012 CHOLHABAgence Nationale de la Recherche ANR-21-CE37-0026 NICOPTOTOUCHFondation pour la Recherche Médicale EQU201903007961Fondation pour la Recherche Médicale FDT202404018105Human Frontier Science Program RGP0035/2020NIH HHS NS111600
6 · The paper itself

Abstract

The medial habenula-interpeduncular nucleus pathway is a highly conserved and densely innervated brain circuit known for its unique cholinergic transmission and exceptional expression of nicotinic acetylcholine receptors. This pathway plays a critical role in regulating motivational and emotional processes, particularly those related to nicotine consumption, avoidance behaviors, and negative emotional states. Recent advances have revealed the intricate cellular architecture and receptor diversity of this system, highlighting how specific subunits of acetylcholine receptors influence both the rewarding and aversive properties of nicotine. Genetic and functional studies in rodents and humans point to this pathway as a key regulator of nicotine intake, with potential implications for addiction treatment. In this review, we examine the organization and molecular composition of nicotinic receptors within this pathway, describe their functional and behavioral roles, and explore how cholinergic signaling contributes to nicotine dependence, stress responses, and affective states.

Indexed as

Avoidance LearningEmotionsHabenulaInterpeduncular NucleusReceptors, NicotinicRewardAnimalsHumansNeural PathwaysNicotineNicotineReceptors, Nicotinicacetylcholineanxietyavoidance behaviorcholinergic synapselaterodorsal tegmentumnicotine addiction

Identifiers

PMID41383023
PMCPMC12699181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.